medigraphic.com
ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)

2015, Number S3

<< Back Next >>

Rev Mex Anest 2015; 38 (S3)

Hormonal dysfunction in the neurocritic patient

de la Cruz-López A, Garrido-Aguirre E

Language: Spanish
References: 7
Page: 441-442
PDF size: 114.59 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R, Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg. 2000;93:743-752.

  2. Dimopoulou I, Tsagarakis S, Kouyialis AT, Roussou P, Assithianakis G, Christoforaki, et al. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels. Crit Care Med. 2004;32:404-408.

  3. Savaridas T, Andrews PJ, Harris B. Cortisol dynamics following acute severe brain injury. Intensive Care Med. 2004;30:1479-1483.

  4. Agha A, Phillips J, Thompson CJ. Hypopituitarism following traumatic brain injury (TBI). Br J Neurosurg. 2007;21:210-216.

  5. Feigin VL, Anderson N, Rinkel GJ, Algra A, van Gijn J, Bennett DA. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev. 2005;CD004583.

  6. Rabinstein AA, Bruder N. Management of hyponatremia and volume contraction. Cuidado Neurocrit. 2011;15:354-360.

  7. Vespa P. Hormonal dysfunction in neurocritical patients. Curr Opin Crit Care. 2013;19:107-112.




2020     |     www.medigraphic.com